A phase II study of allogeneic stem cell transplantation for elderly patients with hematologic malignancies using fludarabine and intravenous busulfan.

Trial Profile

A phase II study of allogeneic stem cell transplantation for elderly patients with hematologic malignancies using fludarabine and intravenous busulfan.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Busulfan (Primary) ; Fludarabine (Primary) ; Ciclosporin; Methotrexate; Mycophenolate mofetil; Tacrolimus
  • Indications Acute myeloid leukaemia; Graft-versus-host disease; Myelodysplastic syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Sep 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 04 Feb 2010 Additional lead trial centres identified as reported by University Hospital Medical Information Network - Japan record.
    • 10 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top